Investment
Features
FeesSafety
Academy
More
Pluang+

Compare SP Funds S&P 500 Sharia Industry Exclusions ETF (SPUS) vs Vir Biotechnology Inc. Common Stock (VIR) Price & Performance

SP Funds S&P 500 Sharia Industry Exclusions ETFTrade
Vir Biotechnology Inc. Common StockTrade

Price performance (Past 24H)

Key statistics

SP Funds S&P 500 Sharia Industry Exclusions ETF vs Vir Biotechnology Inc. Common Stock — how do they compare? SP Funds S&P 500 Sharia Industry Exclusions ETF trades at $59.41 (market cap $3.38B), while Vir Biotechnology Inc. Common Stock trades at $10.2 (market cap $1.80B). The key difference: SP Funds S&P 500 Sharia Industry Exclusions ETF is the larger of the two by market cap, and SP Funds S&P 500 Sharia Industry Exclusions ETF is trading nearer its 52-week high, Vir Biotechnology Inc. Common Stock nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold SP Funds S&P 500 Sharia Industry Exclusions ETF for 66 Days and Vir Biotechnology Inc. Common Stock for 0 Days on average.

SPUSVIR
Market Cap
$3.38B$1.80B
Volume
308,2951,782,836
Sector
Broad Market / FactorHealth
52-Week High
$61.15$11.78
52-Week Low
$46.65$5.12
Typical Hold Time
66 Days0 Days
Enterprise Value
—$1.36B

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

SP Funds S&P 500 Sharia Industry Exclusions ETF

SPUS trades at $60.53, showing minimal daily movement with a slight decline of 0.07%. Technical indicators signal a bullish trend with strong moving average support, though oscillators remain neutral. The ETF maintains regular dividend distributions, with recent payments of $0.03 per share. Short interest saw significant growth in September, increasing 174.5% to 257,142 shares as of September 15, 2026.

The ETF's technical strength supports near-term upside potential, though elevated short interest indicates some bearish sentiment. Dividend consistency provides income appeal, but investors should monitor the growing short position which could increase volatility. The neutral oscillator readings suggest potential consolidation before further directional movement.

Vir Biotechnology Inc. Common Stock

No Aura AI signal available yet.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

SPUS
85% Buy15% Sell
Avg holding period · 66 Days
VIR
51% Buy49% Sell
Avg holding period · 0 Days

About SP Funds S&P 500 Sharia Industry Exclusions ETF

SPUS tracks a market-cap weighted index of S&P 500 stocks that adhere to Sharia law. It screens out companies involved in non-compliant business activities such as alcohol, tobacco, gambling, and conventional finance, as well as excluding sectors like Aerospace & Defense, and Data Processing. By focusing on low-leverage stocks, SPUS provides investors with a value-conscious, ethically-aligned exposure to a diversified portfolio of large-cap U.S. equities.

Read more on SPUS →

About Vir Biotechnology Inc. Common Stock

Vir Biotechnology, Inc. is a US clinical-stage biopharmaceutical company that develops monoclonal antibody-based medicines to treat and prevent serious infectious diseases.

Read more on VIR →